Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Intec Pharma Ltd NTEC
$9.63
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
36.80
-
week52low
8.80
-
Revenue
0
-
P/E TTM
-1
-
Beta
1.13982500
-
EPS
0.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 авг 2021 г. в 04:00
Описание компании
Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
H.C. Wainwright | Neutral | Buy | 07 авг 2019 г. |
Maxim Group | Buy | Buy | 26 мар 2018 г. |
H.C. Wainwright | Buy | 01 мар 2018 г. | |
H.C. Wainwright | Buy | 26 февр 2018 г. | |
Maxim Group | Buy | Buy | 20 ноя 2017 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Navon Nadav | A | 100000 | 100000 | 16 сент 2020 г. |
Linscott Walt Addison | A | 100000 | 100000 | 16 сент 2020 г. |
Sassi Nir | A | 100000 | 100000 | 16 сент 2020 г. |
Hayes William B | A | 40000 | 40000 | 15 июл 2020 г. |
KOZARICH JOHN W | A | 40000 | 40000 | 15 июл 2020 г. |
Meckler Jeffrey A | A | 300000 | 300000 | 15 июл 2020 г. |
MADDALUNA ANTHONY J | A | 40000 | 40000 | 15 июл 2020 г. |
Karah Hila | A | 40000 | 40000 | 15 июл 2020 г. |
Pomerantz Roger | A | 40000 | 40000 | 15 июл 2020 г. |
Linscott Walt Addison | A | 90000 | 90000 | 17 февр 2020 г. |
Свежие комментарии
Свежие комментарии